Glaxo Wellcome Tritec for H. pylori approved Aug. 8.
Executive Summary
GLAXO WELLCOME TRITEC ERA BEGINS: AGENT WILL BE AVAILABLE IN SEPTEMBER following Aug. 8 FDA approval of ranitidine bismuth citrate for use in combination with Abbott's Biaxin (clarithromycin) to treat active duodenal ulcers associated with Helicobacter pylori. Biaxin and Astra Merck's Prilosec (omeprazole) were approved as a combination April 18 and April 15, respectively ("The Pink Sheet" April 22, p. 17).